Ramucirumab for advanced gastric or GEJ adenocarcinoma in previously treated patients with disease progression

被引：0
|
作者：
Abraham, Jame
机构：
来源：
JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY | 2014年 / 12卷 / 12期
关键词：
D O I：
10.12788/jcso.0093
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：428 / 430
页数：3
相关论文
共 50 条
  • [41] NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma
    Cecchini, Michael
    Cleary, James M.
    Shyr, Yu
    Chao, Joseph
    Uboha, Nataliya
    Cho, May
    Shields, Anthony
    Pant, Shubham
    Goff, Laura
    Spencer, Kristen
    Kim, Edward
    Stein, Stacey
    Kortmansky, Jeremy S.
    Canosa, Sandra
    Sklar, Jeffrey
    Swisher, Elizabeth M.
    Radke, Marc
    Ivy, Percy
    Boerner, Scott
    Durecki, Diane E.
    Hsu, Chih-Yuan
    Lorusso, Patricia
    Lacy, Jill
    [J]. BRITISH JOURNAL OF CANCER, 2024, 130 (03) : 476 - 482
  • [42] Fruquintinib plus sintilimab in patients (pts) with either treatment-naive or previously treated advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma: Results from a multicenter, single-arm phase II study
    Wei, X.
    Li, J.
    Yuan, H.
    Zhang, W.
    He, W.
    Lu, P.
    Shi, H.
    Tan, P.
    Fan, S.
    Shi, M.
    Su, W.
    Bai, Y.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S856 - S856
  • [43] NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma
    Michael Cecchini
    James M. Cleary
    Yu Shyr
    Joseph Chao
    Nataliya Uboha
    May Cho
    Anthony Shields
    Shubham Pant
    Laura Goff
    Kristen Spencer
    Edward Kim
    Stacey Stein
    Jeremy S. Kortmansky
    Sandra Canosa
    Jeffrey Sklar
    Elizabeth M. Swisher
    Marc Radke
    Percy Ivy
    Scott Boerner
    Diane E. Durecki
    Chih-Yuan Hsu
    Patricia LoRusso
    Jill Lacy
    [J]. British Journal of Cancer, 2024, 130 : 476 - 482
  • [44] Evaluation of PET Response to Neoadjuvant Therapy for Patients with Gastric and GEJ Adenocarcinoma
    Hernandez, J.
    Beylergil, V.
    Goldman, D.
    Tang, L. H.
    Ilson, D. H.
    Downey, R.
    Strong, V. E.
    Shah, M.
    Goenen, M.
    Schoder, H.
    Coit, D. G.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S166 - S167
  • [45] The impact of nutrition support in advanced gastric adenocarcinoma patients treated with chemotherapy
    Sugiyama, Keiji
    Shiraishi, Kazuhiro
    Motohashi, Takuya
    Onoda, Shinpei
    Noshibori, Riko
    Sato, Mariko
    Shimada, Masaaki
    Hirahsima, Noboru
    Kataoka, Masato
    Kitagawa, Chiyoe
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [46] A phase II trial of irinotecan in patients with previously untreated advanced esophageal and gastric adenocarcinoma
    Enzinger, PC
    Kulke, MH
    Clark, JW
    Ryan, DP
    Kim, H
    Earle, CC
    Vincitore, MM
    Michelini, AL
    Mayer, RJ
    Fuchs, CS
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (12) : 2218 - 2223
  • [47] A Phase II Trial of Irinotecan in Patients with Previously Untreated Advanced Esophageal and Gastric Adenocarcinoma
    Peter C. Enzinger
    Matthew H. Kulke
    Jeffrey W. Clark
    David P. Ryan
    Haesook Kim
    Craig C. Earle
    Michele M. Vincitore
    Ann L. Michelini
    Robert J. Mayer
    Charles S. Fuchs
    [J]. Digestive Diseases and Sciences, 2005, 50 : 2218 - 2223
  • [48] Ramucirumab beyond progression plus TAS-102 in patients with advanced or metastatic esophagogastric adenocarcinoma, after treatment failure on a ramucirumab-based therapy
    Goetze, Thorsten Oliver
    Stein, Alexander
    Lorenzen, Sylvie
    Habibzada, Timorshah
    Goekkurt, Eray
    Herhaus, Peter
    Loose, Maria
    Sookthai, Disorn
    Brulin, Tanita
    Ihrig, Kristina
    Pauligk, Claudia
    Al-Batran, Salah-Eddin
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2023, 153 (10) : 1726 - 1733
  • [49] Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric or Gastroesophageal Junction Cancer
    Kim, Chang Gon
    Jung, Minkyu
    Kim, Hyo Song
    Lee, Choong-kun
    Jeung, Hei-Cheul
    Koo, Dong-Hoe
    Bae, Woo Kyun
    Zang, Dae Young
    Kim, Bum Jun
    Kim, Hyunki
    Yun, Un-Jung
    Che, Jingmin
    Park, Sejung
    Kim, Tae Soo
    Kwon, Woo Sun
    Park, Juin
    Cho, Sang Woo
    Nam, Chung Mo
    Chung, Hyun Cheol
    Rha, Sun Young
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (27) : 4394 - +
  • [50] Ramucirumab Beyond Disease Progression After Paclitaxel Plus Ramucirumab in Gastric Cancer: A Phase II Trial
    Sato, Yasuyoshi
    Yamashita, Hiroharu
    Yagi, Koichi
    Nomura, Sachiyo
    Seto, Yasuyuki
    [J]. ANTICANCER RESEARCH, 2024, 44 (07) : 3125 - 3131
12345